


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+8.32%
-8.81%
-3.80%
-9.63%
LLY
Eli Lilly and
$987.45

Login to see Eli Lilly and (LLY) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Technical Indicators

3+ Days Up
LLY Price Performance
$931.09 (+6.05%)
$1058.18 (-6.68%)
$982.22 (+0.53%)
$755.11 (+30.77%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Revenue increase YoY
Earnings increase YoY
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
LLY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook
LLY has Low risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Mar 31, 2026
Reiterate
Overweight
Barclays
Apr 27, 2026
Upgrade
become
Truist Securities
Apr 27, 2026
Upgrade
see
BofA
Nov 25, 2025
Reiterate
Outperform
Bernstein
Nov 25, 2025
Reiterate
Overweight
Morgan Stanley
NVO
Novo Nordisk A/S
44.94
+1.10%
ABBV
AbbVie
206.39
-0.87%
JNJ
Johnson & Johnson
225.95
+0.78%
JNJ
Johnson & Johnson
225.95
+0.78%
JNJ
Johnson & Johnson
225.95
+0.78%
What is LLY current stock price?
What are LLY stock strengths?
What is LLY Risk Level?
What is LLY market cap and volume?
What is LLY current Stock IQ?
Should I buy LLY stock right now?
Is LLY a Strong Buy right now?
What does a 'Strong Buy' rating mean for LLY?
What does a 'Strong Sell' rating mean for LLY?
What factors influence LLY's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
LLY
Eli Lilly and
Current Price
$987.45
Runners Also Watch
NVO
Novo Nordisk A/S
44.94
+1.10%
ABBV
AbbVie
206.39
-0.87%
JNJ
Johnson & Johnson
225.95
+0.78%
JNJ
Johnson & Johnson
225.95
+0.78%
JNJ
Johnson & Johnson
225.95
+0.78%

LLY Price Performance
$931.09 (+6.05%)
$1058.18 (-6.68%)
$982.22 (+0.53%)
$755.11 (+30.77%)
LLY Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Revenue increase YoY
Earnings increase YoY
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
LLY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook
LLY has Low risk level

Overall Wall Street Rating
LLY Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Technical Indicators

3+ Days Up
LLY Trading Signals
LLY has positive earnings news: Earnings Increase. What&apos.s behind Eli Lilly&apos.s down-and-up day after last week&apos.s post-earnings surge. Every weekday the Investing Club releases the Homestre...
LLY has positive earnings news: Revenue Increase. Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%. The post Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soa...
LLY received an analyst buy rating. JonesResearch Reiterates Buy on AbCellera Biologics (ABCL). AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the 8 Best Healthcare AI Stocks to Buy Ac...
LLY received an analyst buy rating. This Pharma Stock Keeps Earning My Money Here’.s Why. The post This Pharma Stock Keeps Earning My Money Here’.s Why appeared first on 24/7 W...
LLY received an analyst buy rating. 5 Best Healthcare AI Stocks to Buy According to Analysts. In this article we will list the 5 Best Healthcare AI Stocks to Buy According to Analysts. P...
LLY received an analyst price target change. Barclays Hikes Eli Lilly Price Target to $1400: Tirzepatide Momentum Steals the Show. The post Barclays Hikes Eli Lilly Price Target to $1400: Tirzepa...
LLY received an analyst buy rating. 5 Best Healthcare AI Stocks to Buy According to Analysts. In this article we will list the 5 Best Healthcare AI Stocks to Buy According to Analysts. P...
LLY reported significant insider selling. Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering. PHILADELPHIA May 04 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio Inc. (Cabaletta o...
LLY has closed up for 4 consecutive days
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
$196.50 Target $900 +356%
Read MoreNVIDIA sits at $196.50, well below its 52-week high of $216.83 but holding cleanly above its 20-day, 50-day, and 200-day moving averages at $191.76, $187.85, and $183.05 respectively. That k...